Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Jiménez, Viviana Cobos ^a   Booiman, Thijs ^a   De Taeye, Steven W ^a   Van Dort, Karel A ^a   Rits, Maarten A N ^a   Hamann, Jörg ^a   Kootstra, Neeltje A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868291996     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00763     Document Type: Article

References (64)

1. Guadalupe, M. et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J.Virol. 80, 8236-8247 (2006). (Pubitemid 44182323)
2. Poles, M. A. et al. Lack of decay of HIV-1 in gut-Associated lymphoid tissue reservoirs in maximally suppressed individuals. J.Acquir.Immune.Defic. Syndr. 43, 65-68 (2006). (Pubitemid 44306490)
3. Chun, T. W. et al. Persistence of HIV in gut-Associated lymphoid tissue despite long-term antiretroviral therapy. J.Infect.Dis. 197, 714-720 (2008).
4. Ho, D. D., Rota, T. R. & Hirsch, M. S. Infection of monocyte/macrophages by human T lymphotropic virus type III. J.Clin.Invest. 77, 1712-1715 (1986). (Pubitemid 16047120)
5. Nicholson, J. K., Cross, G. D., Callaway, C. S. & McDougal, J. S. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-Associated virus (HTLV-III/LAV). J.Immunol. 137, 323-329 (1986). (Pubitemid 16100307)
6. Gendelman, H. E. et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J.Exp.Med. 167, 1428-1441 (1988).
7. Dornadula, G. et al. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA. 282, 1627-1632 (1999). (Pubitemid 29513968)
8. Fischer M. et al. Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy. AIDS Res.Hum.Retroviruses. 16, 1135-1140 (10-8-2000).
9. Schuitemaker, H. et al. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J.Clin.Invest. 89, 1154-1160 (1992).
10. Rich, E. A., Chen, I. S., Zack, J. A., Leonard, M. L. & O'Brien, W. A. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J.Clin.Invest. 89, 176-183 (1992).
11. Sonza, S. et al. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J.Virol. 70, 3863-3869 (1996). (Pubitemid 26157366)
12. Wang, X. et al. Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood. 113, 671-674 (2009).
13. Peng, G. et al. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood. 110, 393-400 (2007). (Pubitemid 47026861)
14. Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat.Rev.Immunol. 8, 958-969 (2008).
15. Martinez, F. O., Helming, L. & Gordon, S. Alternative activation of macrophages: an immunologic functional perspective. Annu.Rev.Immunol. 27, 451-483 (2009).
16. Montaner, L. J., Bailer, R. T. & Gordon, S. IL-13 acts on macrophages to block the completion of reverse transcription, inhibit virus production, and reduce virus infectivity. J.Leukoc.Biol. 62, 126-132 (1997). (Pubitemid 27321750)
17. Wang, J., Roderiquez, G., Oravecz, T. & Norcross, M. A. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J.Virol. 72, 7642-7647 (1998). (Pubitemid 28377903)
18. Kazazi, F. et al. Recombinant interleukin-4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J.Gen.Virol. 73, 941-948 (1992).
19. Naif, H., Ho-Shon, M., Chang, J. & Cunningham, A. L. Molecular mechanisms of IL-4 effect on HIV expression in promonocytic cell lines and primary human monocytes. J.Leukoc.Biol. 56, 335-339 (1994). (Pubitemid 24295802)
20. Naif, H. M. et al. The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication. J.Immunol. 158, 501-511 (1-1-1997).
21. Kornbluth, R. S., Oh, P. S., Munis, J. R., Cleveland, P. H. & Richman, D. D. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J.Exp.Med. 169, 1137-1151 (1989). (Pubitemid 19085845)
22. Cassol, E., Cassetta, L., Rizzi, C., Alfano, M. & Poli, G. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J.Immunol. 182, 6237-6246 (2009).
23. Cassol, E., Cassetta, L., Alfano, M. & Poli, G. Macrophage polarization and HIV-1 infection. J.Leukoc.Biol. 87, 599-608 (2010).
24. Kootstra, N. A., van't Wout, A. B., Huisman, J. G., Miedema, F. & Schuitemaker, H. Interference of IL-10 with HIV-1 replication in primary monocyte derived macrophages. J.Virol. 68, 6967-6975 (1994). (Pubitemid 24328746)
25. Montaner, L. J., Griffin, P. & Gordon, S. Interleukin 10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro. J.Gen.Virol. 75, 3393-3400 (1994).
26. Naif, H. M., Chang, J., Ho-Shon, M., Li, S. & Cunningham, A. L. Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression. AIDS Res.Hum.Retroviruses. 12, 1237-1245 (1996). (Pubitemid 26306972)
27. Nold, M. F. et al. Endogenous IL-32 controls cytokine and HIV-1 production. J.Immunol. 181, 557-565 (2008).
28. Rasool, S. T. et al. Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol.Lett. 117, 161-167 (2008).
29. Tissot, C. & Mechti, N. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J.Biol.Chem. 270, 14891-14898 (1995).
30. Yin, L., Braaten, D. & Luban, J.Human immunodeficiency virus type 1replication is modulated by host cyclophilin A expression levels. J.Virol. 72, 6430-6436 (1998). (Pubitemid 28323955)
31. Zhang, H. et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature. 424, 94-98 (2003). (Pubitemid 36834848)
32. Harris, R. S. et al. DNA deamination mediates innate immunity to retroviral infection. Cell. 113, 803-809 (2003). (Pubitemid 36724943)
33. Sokolskaja, E., Sayah, D. M. & Luban, J. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J.Virol. 78, 12800-12808 (2004). (Pubitemid 39507788)
34. Stremlau, M. et al. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature. 427, 848-853 (26-2-2004).
35. Bishop, K. N., Holmes, R. K. & Malim, M. H. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J.Virol. 80, 8450-8458 (2006). (Pubitemid 44384857)
36. Bouazzaoui, A. et al. Stimulated trans-Acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virology. 356, 79-94 (2006). (Pubitemid 44750026)
37. Barr, S. D., Smiley, J. R. & Bushman, F. D. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS.Pathog. 4, e1000007 (2008).
38. Neil, S. J., Zang, T. & Bieniasz, P. D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 451, 425-430 (2008). (Pubitemid 351158893)
39. Yan, N., Regalado-Magdos, A. D., Stiggelbout, B., Lee-Kirsch, M. A. & Lieberman, J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat.Immunol. 11, 1005-1013 (2010).
40. Goldstone, D. C. et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature. (2011).
41. Laguette, N. et al. SAMHD1 is the dendritic-And myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature. 474, 654-657 (2011).
42. Hrecka, K. et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature. 474, 658-661 (2011).
43. Pertel, T. et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature. 472, 361-365 (2011).
44. Kajaste-Rudnitski, A. et al. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements. J.Virol. 85, 5183-5196 (2011).
45. Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686 (2004). (Pubitemid 39457982)
46. Gordon, S. & Martinez, F. O. Alternative activation of macrophages: mechanism and functions. Immunity. 32, 593-604 (2010).
47. Deeks, S. G.HIV infection, inflammation, immunosenescence, and aging. Annual Review of Medicine. 62, 141-155 (2011).
48. Montaner, L. J. et al. Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. J.Immunol. 162, 4606-4613 (15-4-1999).
49. Goujon, C. & Malim, M. H. Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells. J.Virol. 84, 9254-9266 (2010).
50. Cheney, K. M. & McKnight, A. Interferon-Alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication. PLoS.One. 5, e13521 (2010).
51. Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 472, 481-485 (2011).
52. Peng, G., Lei, K. J., Jin, W., Greenwell-Wild, T. & Wahl, S. M. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J.Exp.Med. 203, 41-46 (23-1-2006).
53. Lahouassa, H. et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat.Immunol. 13, 223-228 (2012).
54. Tsang, J. et al. HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS. 23, 2255-2263 (2009).
55. Manel, N. et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature. 467, 214-217 (2010).
56. Netea, M. G. et al. Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc.Natl.Acad.Sci.U.S.A. 105, 3515-3520 (2008). (Pubitemid 351723584)
57. Bergamaschi, A. et al. The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages. J.Virol. 83, 12253-12265 (2009).
58. He, J. et al. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J.Virol. 69, 6705-6711 (1995).
59. van't Wout, A. B., Schuitemaker, H. & Kootstra, N. A. Isolation and propagation of HIV-1 on peripheral blood mononuclear cells. Nat.Protoc. 3, 363-370 (2008). (Pubitemid 351372226)
60. Tersmette, M. et al. Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV-p24 gag. Virology. 171, 149-155 (1989). (Pubitemid 19180782)
61. Kootstra, N. A. & Schuitemaker, H. Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages. Virology. 253, 170-180 (20-1-1999).
62. Butler, S. L., Hansen, M. S. & Bushman, F. D. A quantitative assay for HIV DNA integration in vivo. Nat Med. 7, 631-634 (2001). (Pubitemid 32448333)
63. Folks, T. M. et al. Biological and biochemical characterization of a cloned Leu-3-cell surviving infection with the acquired immune deficiency syndrome retrovirus. J.Exp.Med. 164, 280-290 (1986). (Pubitemid 16069238)
64. Huang, J. et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD41 T lymphocytes. Nat.Med. 13, 1241-1247 (2007). (Pubitemid 47530631)